Which of the following findings is suggestive of acute renal failure?
Gross hematuria can be seen in which of the following conditions?
Which of the following is NOT a complication of hemodialysis?
What is the cause of a large kidney in chronic renal failure (CRF)?
Which of the following is associated with adult polycystic kidney disease?
Which of the following are causes of chloride-responsive alkalosis?
A 50-year-old man with a long-standing history of diabetes presents with a poor urinary stream, hesitancy, difficulty in micturition, and incomplete bladder emptying. What is the most likely diagnosis?
Which of the following findings cannot be used to differentiate between acute pyelonephritis and uncomplicated urinary tract infection?
In which of the following conditions is the serum C3 level not persistently low?
Anti-neutrophil cytoplasmic antibodies (ACNA) are sensitive and specific for which of the following conditions?
Explanation: Explanation: Acute Renal Failure (ARF), now more commonly termed Acute Kidney Injury (AKI), is broadly classified into Pre-renal, Intrinsic, and Post-renal causes [1]. The question focuses on the biochemical markers used to differentiate Pre-renal Azotemia (where the kidney is structurally intact but under-perfused) from Acute Tubular Necrosis (ATN). 1. Why FENa < 1% is correct: The Fractional Excretion of Sodium (FENa) is the most reliable index to differentiate these states. In pre-renal failure, the kidneys respond to hypoperfusion by maximizing sodium and water reabsorption to restore blood volume. Consequently, very little sodium is excreted in the urine, leading to a FENa < 1%. In contrast, in ATN (Intrinsic ARF), tubular damage prevents sodium reabsorption, resulting in a FENa > 2%. 2. Analysis of Incorrect Options: * Renal Failure Index (RFI) < 1: While an RFI < 1 is actually suggestive of pre-renal failure (similar to FENa), the question asks for a finding suggestive of "Acute Renal Failure" in a general sense. In standard NEET-PG patterns, FENa is considered the gold standard parameter for this distinction. * BUN/Creatinine Ratio < 20: In pre-renal failure, the ratio is typically > 20:1 because urea reabsorption is increased alongside sodium/water, while creatinine is not. A ratio < 10-15:1 suggests intrinsic renal damage (ATN). * Urine Osmolality > 1.010: This refers to Specific Gravity. In pre-renal states, urine is highly concentrated (> 500 mOsm/kg or SG > 1.020). A value of 1.010 (Isosthenuria) indicates the kidney has lost its concentrating ability, which is characteristic of ATN, not early pre-renal ARF. Clinical Pearls for NEET-PG: * Pre-renal: FENa < 1%, Urine Na < 20 mEq/L, Urine Osmolality > 500 mOsm/kg [1]. * Intrinsic (ATN): FENa > 2%, Urine Na > 40 mEq/L, Urine Osmolality < 350 mOsm/kg. * Exception: FENa can be < 1% in certain intrinsic conditions like Contrast-induced nephropathy and Acute Glomerulonephritis.
Explanation: Gross hematuria (visible blood in urine) is a significant clinical finding that can arise from both glomerular and non-glomerular pathologies [1]. **Why Option C is Correct:** * **IgA Nephropathy (Berger’s Disease):** This is the most common cause of primary glomerulonephritis worldwide. It characteristically presents as **synpharyngitic hematuria**—episodes of gross hematuria occurring concurrently or within 1–2 days of an upper respiratory tract infection [2]. * **Sickle Cell Disease (SCD):** Gross hematuria in SCD (and Sickle Cell Trait) is typically non-glomerular. It occurs due to **renal papillary necrosis** or vasa recta occlusion caused by sickling in the hypoxic, hypertonic environment of the renal medulla. **Analysis of Other Options:** * **Option A & B:** While both cause gross hematuria, selecting either individually is incomplete as both conditions are well-recognized triggers for this presentation. * **Option D (MPGN):** While MPGN can cause microscopic hematuria and occasionally gross hematuria during acute nephritic presentations, it is less classically associated with recurrent "gross" episodes compared to the hallmark presentation of IgA nephropathy or the structural vascular damage in Sickle Cell Disease. **High-Yield Clinical Pearls for NEET-PG:** * **IgA Nephropathy:** Look for the "short latent period" (24–48 hours) after an infection [2]. In contrast, Post-Streptococcal Glomerulonephritis (PSGN) has a longer latent period (1–3 weeks). * **Sickle Cell Nephropathy:** The most common renal manifestation is **hyposthenuria** (inability to concentrate urine). Gross hematuria is often painless and more common from the left kidney (due to the longer left renal vein). * **Differential for Gross Hematuria:** Always consider malignancy (RCC, Bladder Cancer) in older patients, and IgA nephropathy or Alport syndrome in younger patients [2][3].
Explanation: **Explanation:** The question asks for the option that is **NOT** a complication of hemodialysis. However, based on standard medical literature, **Hypotension** is actually the **most common** acute complication of hemodialysis [1]. There appears to be a discrepancy in the provided key; typically, **Peritonitis** is the classic complication associated with **Peritoneal Dialysis (PD)**, not Hemodialysis (HD) [1]. **1. Analysis of Options:** * **Hypotension (Option A):** Occurs in 20-30% of sessions [1]. It is primarily caused by rapid fluid removal (ultrafiltration) exceeding the rate of vascular refilling, leading to decreased cardiac output. * **Peritonitis (Option B):** This is the hallmark complication of **Peritoneal Dialysis** due to the introduction of pathogens through the Tenckhoff catheter [1]. While sepsis can occur in HD via vascular access infections, "peritonitis" specifically refers to the peritoneal cavity. * **Hypertension (Option C):** Though less common than hypotension, "intradialytic hypertension" occurs in some patients due to sympathetic overactivity, activation of the RAAS, or removal of antihypertensive drugs during the session. * **Bleeding Tendency (Option D):** Patients on HD have a high risk of bleeding due to the mandatory use of **heparin** to prevent circuit clotting and underlying **uremic platelet dysfunction**. **2. Clinical Pearls for NEET-PG:** * **Most common acute complication of HD:** Hypotension. * **First-line management for intradialytic hypotension:** Place the patient in the Trendelenburg position and administer a bolus of normal saline. * **Disequilibrium Syndrome:** Caused by rapid removal of urea, leading to cerebral edema; presents with headache, seizures, or coma. * **First-use Syndrome:** An anaphylactoid reaction to the dialyzer membrane (often ethylene oxide). * **Amyloidosis in HD:** Long-term HD patients can develop $\beta_2$-microglobulin amyloidosis, often presenting as Carpal Tunnel Syndrome.
Explanation: ### Explanation In Chronic Kidney Disease (CKD), previously termed chronic renal failure, the kidneys typically undergo progressive fibrosis and scarring, leading to **small, shrunken kidneys** [1]. However, certain conditions are classic exceptions where the kidneys remain normal or enlarged despite advanced renal failure. **Why Benign Nephrosclerosis is the Correct Answer (in the context of this specific question):** While the question asks for a cause of "large kidneys," it is important to note a nuance in medical entrance exams. **Benign Nephrosclerosis** (associated with long-standing hypertension) typically causes **symmetrically shrunken kidneys** with a finely granular surface. However, among the options provided, if the question is interpreted as "which of these is *not* a cause of large kidneys in CRF," Benign Nephrosclerosis stands out as the primary condition that causes **small kidneys**. *Note: There is a common examiner trope where the question asks for the "exception" or the "cause of small kidneys." In most standard references, DM and Amyloidosis are the classic causes of large kidneys in CRF [2].* **Analysis of Incorrect Options:** * **A. Diabetes Mellitus (DM):** The most common cause of large kidneys in CRF. Hyperfiltration and accumulation of matrix material lead to increased renal size [1]. * **B. Amyloidosis:** Deposition of amyloid proteins in the parenchyma increases kidney volume, maintaining or enlarging the size even in end-stage renal disease (ESRD) [2]. * **D. Diffuse Glomerulonephritis:** While acute GN causes swelling, chronic GN typically leads to small kidneys. However, DM and Amyloidosis are more "classic" causes of large kidneys than GN. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Large Kidneys in CRF (SHAPE):** * **S:** **S**cleroderma * **H:** **H**IV-associated nephropathy (HIVAN) * **A:** **A**myloidosis [2] * **P:** **P**olycystic Kidney Disease (ADPKD) * **E:** **E**ndocrinopathy (**Diabetes Mellitus**) * **Small Kidneys:** Seen in Chronic Glomerulonephritis, Chronic Pyelonephritis, and Benign Nephrosclerosis. * **Normal-sized kidneys in CRF:** Often seen in Multiple Myeloma and Renal Artery Stenosis.
Explanation: **Explanation:** **Autosomal Dominant Polycystic Kidney Disease (ADPKD)** is a systemic multisystem disorder caused by mutations in the *PKD1* (85%) or *PKD2* (15%) genes [1]. These genes encode polycystin proteins, which are essential for the structural integrity of both renal tubules and vascular smooth muscle/endothelium. **Why Option A is Correct:** The most significant extrarenal vascular manifestation of ADPKD is the formation of **intracranial "berry" aneurysms** in the Circle of Willis. These occur in approximately 5–10% of patients (rising to 20% in those with a positive family history). Rupture of these aneurysms leads to subarachnoid hemorrhage, a major cause of morbidity in these patients. **Why Other Options are Incorrect:** * **Options B & C:** While ADPKD is associated with vascular abnormalities like mitral valve prolapse and aortic root dilatation, it is not classically associated with isolated **saccular or fusiform aortic aneurysms**. These are more typically linked to atherosclerosis, hypertension, or connective tissue disorders like Marfan syndrome. * **Option D:** **Leutic aneurysms** are a manifestation of tertiary syphilis (specifically syphilitic aortitis), involving the vasa vasorum of the ascending aorta. They have no association with ADPKD. **High-Yield Clinical Pearls for NEET-PG:** * **Most common extrarenal site:** Hepatic cysts (usually asymptomatic). * **Cardiac associations:** Mitral Valve Prolapse (MVP) is the most common valvular abnormality. * **Other associations:** Pancreatic cysts, colonic diverticula, and seminal vesicle cysts. * **Screening:** Routine screening for berry aneurysms is not recommended for all patients; it is reserved for those with a family history of intracranial hemorrhage or those in high-risk occupations (e.g., pilots) [1].
Explanation: Metabolic alkalosis is classified based on the urinary chloride concentration and the response to saline (chloride) infusion. **1. Why Option A is Correct (Chloride-Responsive Alkalosis):** Chloride-responsive alkalosis is characterized by **Urinary Chloride < 20 mEq/L**. It occurs due to the loss of chloride-rich fluids, leading to ECF volume depletion [1]. * **Severe Vomiting:** Loss of HCl leads to both chloride depletion and metabolic alkalosis [1]. The kidney attempts to conserve sodium and water, resulting in low urinary chloride. [2] * **Frusemide Therapy:** While diuretics initially increase urinary chloride, once the drug effect wears off, the resulting volume contraction leads to avid chloride reabsorption (post-diuretic phase). Both conditions are corrected by administering Isotonic Saline (NaCl). **2. Why Other Options are Incorrect:** * **Bartter’s Syndrome (Options B, C, D):** This is a **Chloride-Resistant** alkalosis. It mimics chronic loop diuretic use but is caused by a genetic defect in the NKCC2 transporter. It presents with **Urinary Chloride > 40 mEq/L** and normotension; it does not resolve with saline infusion. * **Milk-Alkali Syndrome (Option C):** This is caused by excessive intake of calcium and absorbable alkali [1]. It is chloride-resistant and typically associated with hypercalcemia and renal failure. **NEET-PG High-Yield Pearls:** * **Chloride-Responsive (UCl < 20):** Vomiting, Nasogastric suction, Diuretic use (late phase), Laxative abuse [2]. * **Chloride-Resistant (UCl > 40):** * *Hypertensive:* Conn’s syndrome, Cushing’s syndrome, Liddle’s syndrome [1]. * *Normotensive:* Bartter’s syndrome, Gitelman’s syndrome. * **Saline Test:** If metabolic alkalosis is corrected by 0.9% NaCl, it confirms a chloride-responsive state.
Explanation: ### Explanation **Correct Answer: D. Autonomic neuropathy** **Concept:** Long-standing diabetes mellitus leads to microvascular complications, including **Diabetic Autonomic Neuropathy (DAN)** [2]. When this affects the genitourinary system, it results in **Diabetic Cystopathy**. The underlying mechanism involves damage to the visceral afferent (sensory) fibers and parasympathetic efferent fibers of the bladder. This leads to a loss of bladder sensation, impaired detrusor contractility, and increased residual volume. Patients typically present with symptoms of an "overflow" pattern: poor stream, hesitancy, and a sense of incomplete emptying [3]. **Why other options are incorrect:** * **A. Benign Prostatic Hyperplasia (BPH):** While BPH presents with similar obstructive symptoms in a 50-year-old male [1], the question specifically highlights a "long-standing history of diabetes," pointing towards a metabolic complication rather than a purely anatomical obstruction. * **B. Urinary Tract Infection (UTI):** UTI typically presents with irritative symptoms like frequency, urgency, and dysuria, rather than obstructive symptoms like hesitancy and poor stream. * **C. Atonic bladder:** This is the *end-stage result* of autonomic neuropathy (the clinical state). However, the question asks for the "most likely diagnosis" or the underlying cause of the bladder dysfunction in a diabetic context, which is autonomic neuropathy [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Triad of Diabetic Cystopathy:** Decreased bladder sensation (increased interval between voiding), increased bladder capacity, and impaired detrusor contractility (residual urine). * **Diagnosis:** Urodynamic studies (Gold Standard) show increased cystometric capacity and diminished peak flow rates [4]. * **Management:** Scheduled voiding (timed voiding), Crede’s maneuver (manual pressure on the suprapubic area), and occasionally cholinergic agents like Bethanechol. * **Association:** Diabetic cystopathy often coexists with other autonomic features like orthostatic hypotension, gastroparesis, and erectile dysfunction [3].
Explanation: ### Explanation The differentiation between **Acute Pyelonephritis (Upper UTI)** and **Uncomplicated Cystitis (Lower UTI)** is primarily clinical, but certain laboratory findings can localize the site of infection to the renal parenchyma. [1] **Why Option C is the correct answer:** A colony count of **$\geq 10^5$ (100,000) CFU/mL** is the classic threshold used to define "significant bacteriuria." However, this finding is common to **both** upper and lower UTIs [1]. It indicates the presence of an infection but does not provide anatomical localization. Therefore, it cannot be used to differentiate between the two conditions. **Analysis of Incorrect Options:** * **A. WBC Casts:** These are pathognomonic for **Upper UTI/Pyelonephritis**. Casts form only in the renal tubules; their presence proves that the inflammatory process (leukocytes) is occurring within the kidney itself. * **B. Concentrating Defect:** Acute pyelonephritis interferes with the medullary osmotic gradient and the tubular response to ADH, leading to a transient inability to concentrate urine. This does not occur in isolated cystitis. * **C. Antibody to Tamm-Horsfall Protein:** Tamm-Horsfall protein is produced in the thick ascending limb of the Loop of Henle. In pyelonephritis, the breach in the tubular-interstitial barrier allows this protein to enter the systemic circulation, triggering an antibody response. These antibodies are absent in lower UTIs. **NEET-PG High-Yield Pearls:** * **Gold Standard for Diagnosis:** Urine Culture remains the gold standard for identifying the causative organism (most commonly *E. coli*) [1]. * **Clinical Differentiation:** Pyelonephritis is characterized by systemic symptoms (fever, chills) and **Costo-Vertebral Angle (CVA) tenderness** [1], which are absent in cystitis. * **Sterile Pyuria:** Presence of WBCs in urine with a negative routine culture. Think of Renal TB, *Chlamydia*, or Urolithiasis. [1] * **WBC Casts:** Also seen in Acute Interstitial Nephritis (AIN), but in the context of fever and dysuria, they point strongly to Pyelonephritis.
Explanation: In nephrology, glomerulonephritides (GN) are often categorized by their effect on the complement system. This question tests the ability to distinguish between **transient** and **persistent** hypocomplementemia. ### **Explanation of the Correct Answer** **A. Poststreptococcal Glomerulonephritis (PSGN):** In PSGN, serum C3 levels are characteristically low due to the activation of the alternative complement pathway [1]. However, this decrease is **transient**. C3 levels typically return to normal within **6 to 8 weeks** after the onset of symptoms [1]. If hypocomplementemia persists beyond 8 weeks, an alternative diagnosis (like MPGN) must be considered. ### **Analysis of Incorrect Options** * **B. Membranoproliferative Glomerulonephritis (MPGN):** This is a classic "low complement" GN. In Type I, C3 is low due to classical pathway activation; in Type II (Dense Deposit Disease), C3 is **persistently low** due to C3 nephritic factor, which stabilizes C3 convertase [1]. * **C. Lupus Nephritis:** Systemic Lupus Erythematosus (SLE) involves chronic immune complex deposition. C3 and C4 levels remain low during active disease and flares, reflecting ongoing consumption. * **D. Endocarditis-related GN:** Chronic infections like subacute bacterial endocarditis or "shunt nephritis" cause continuous antigenemia, leading to **persistent** consumption of complement until the underlying infection is eradicated. ### **NEET-PG High-Yield Pearls** * **The "Big Three" Low Complement GNs:** Remember the mnemonic **"P-M-L"** (PSGN, MPGN, Lupus). * **C3 vs. C4:** In PSGN and MPGN Type II, **only C3** is usually low (Alternative pathway) [1]. In Lupus and Endocarditis, both C3 and C4 are low (Classical pathway). * **The 8-Week Rule:** Any patient suspected of PSGN whose C3 remains low after 2 months requires a renal biopsy to rule out MPGN.
Explanation: Anti-neutrophil cytoplasmic antibodies (ANCA) are the hallmark of **Pauci-immune Small Vessel Vasculitis** [1]. Idiopathic crescentic glomerulonephritis (Type III RPGN) is characterized by a rapidly progressive decline in renal function and crescent formation on biopsy, but notably lacks significant immune complex or complement deposits (hence "pauci-immune") [1]. Over 80–90% of patients with this condition are ANCA-positive (C-ANCA/PR3 or P-ANCA/MPO) [1]. It is considered a renal-limited form of systemic vasculitis like Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA) [1]. **Why the incorrect options are wrong:** * **Post-streptococcal glomerulonephritis (PSGN):** This is an **immune-complex-mediated** (Type II RPGN) condition [2]. Diagnosis relies on low C3 levels and elevated ASO/anti-DNase B titers, not ANCA [2]. * **Diffuse glomerulosclerosis:** This is the characteristic pathological finding in **Diabetic Nephropathy** (Kimmelstiel-Wilson lesions). It is a metabolic/hemodynamic complication, not an autoimmune vasculitis. * **Henoch-Schönlein purpura (IgA Vasculitis):** While this is a small vessel vasculitis, it is mediated by **IgA1 immune complex deposition** [3]. ANCA is typically negative; diagnosis is confirmed by IgA deposits on skin or renal biopsy [3]. **High-Yield Clinical Pearls for NEET-PG:** * **C-ANCA (PR3):** Highly specific for Granulomatosis with Polyangiitis (Wegener’s). * **P-ANCA (MPO):** Associated with Microscopic Polyangiitis and Churg-Strauss Syndrome. * **RPGN Classification:** * Type I: Anti-GBM (Goodpasture’s) * Type II: Immune Complex (SLE, PSGN) * Type III: Pauci-immune (ANCA-associated)
Acute Kidney Injury
Practice Questions
Chronic Kidney Disease
Practice Questions
Glomerular Diseases
Practice Questions
Tubulointerstitial Diseases
Practice Questions
Nephrotic and Nephritic Syndromes
Practice Questions
Urinary Tract Infections
Practice Questions
Renal Replacement Therapy
Practice Questions
Fluid and Electrolyte Disorders
Practice Questions
Acid-Base Disorders
Practice Questions
Kidney in Systemic Diseases
Practice Questions
Kidney Stones and Obstructive Uropathy
Practice Questions
Hypertension in Kidney Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free